Immobility is treated as an operational behavioral endpoint: the assay records how long a mouse stops making escape-directed movements during the defined observation period. This measure does not directly diagnose depression or reproduce the full human condition. Its value lies in comparing behavioral changes across controlled groups, especially when evaluating whether an intervention alters stress-coping behavior.
Strain, handling, and other experimental conditions can influence the amount of immobility observed, so they must be controlled or kept consistent between groups. These variables can affect behavioral performance independently of a treatment. Careful standardization makes group differences easier to interpret and reduces the risk of attributing procedural variation to altered mood-related behavior.
A reduction in immobility after treatment can indicate antidepressant-like activity within the assay, but it remains a preclinical behavioral result rather than evidence of clinical antidepressant efficacy. Interpretation depends on comparison with an untreated or otherwise appropriate control under the same conditions. The assay therefore supports screening while preserving a distinction between behavioral activity and human therapeutic benefit.
Researchers suspend the mouse by its tail, observe escape-directed movements throughout a defined testing interval, and record periods of motionlessness. Scoring may be performed manually during the assay or from a video recording. Keeping the observation window and scoring approach consistent across animals allows results to be compared within the experiment.
Manual and video-based analysis provide two ways to quantify the same behavioral endpoint: periods of motionlessness. Manual observation allows scoring during the assay, whereas video recording permits the behavior to be reviewed as part of analysis. Whichever approach is selected, applying the same scoring rules and defined interval is important for consistent measurements.
Tail Suspension Scoring is useful when neuroscience studies need a behavioral readout for preclinical antidepressant screening or for examining neural pathways involved in mood regulation. Treatment-related differences can identify compounds or experimental conditions that merit further study. Because the result reflects stress-coping behavior in mice, it should be integrated with the broader experimental context rather than treated as a complete model of mood disorders.